DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,978,900
-54.7%
870,0000.0%0.22%
-53.2%
Q2 2023$22,019,700
+50.7%
870,000
-3.3%
0.47%
+0.9%
Q4 2019$14,607,000
-59.1%
900,000
-10.0%
0.47%
-66.9%
Q4 2017$35,750,000
+309.9%
1,000,000
+289.9%
1.41%
+300.9%
Q2 2014$8,721,000
+137.2%
256,500
+119.8%
0.35%
+134.0%
Q1 2014$3,676,000116,6890.15%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders